10x Genomics 

$21.2
167
-$0.51-2.36% Today

Statistics

Day High
21.52
Day Low
21.4
52W High
26.02
52W Low
7.72
Volume
4.01
Avg. Volume
-
Mkt Cap
2.49B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

7MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.47
-0.22
0.03
0.28
Expected EPS
-0.277767
Actual EPS
N/A

Financials

-6.77%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
1.29BRevenue
-87.09MNet Income

Analyst Ratings

23.09Average Price Target
The highest estimate is 32.00.
From 12 ratings within the last 6 months. This is not an investment recommendation.
Buy
33%
Hold
67%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 0A88.LSE. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap20.57B
Illumina provides sequencing and array-based solutions for genetic analysis, directly competing in the genomics space with technologies that overlap with 10x Genomics' offerings.
Pacific Biosciences of California
PACB
Mkt Cap510.38M
Pacific Biosciences offers long-read sequencing technologies that compete with 10x Genomics' products for genomic and transcriptomic analysis.
Bionano Genomics
BNGO
Mkt Cap14.31M
Bionano Genomics provides optical genome mapping solutions, which compete with 10x Genomics' chromosomal conformation capture technologies.
Intellia Therapeutics
NTLA
Mkt Cap1.77B
Intellia Therapeutics is involved in CRISPR gene editing, a field that requires detailed genomic analysis, where 10x Genomics' products are used.
CRISPR Therapeutics
CRSP
Mkt Cap5.57B
CRISPR Therapeutics is another key player in the gene editing space, relying on genomic insights where 10x Genomics' technologies can be applied.
Editas Medicine
EDIT
Mkt Cap341.57M
Editas Medicine operates in the genome editing sector, competing for the same genomic analysis market as 10x Genomics.
Teladoc Health
TDOC
Mkt Cap1.03B
Teladoc Health, while primarily a telehealth company, is expanding into primary care and chronic condition monitoring, indirectly competing with 10x Genomics in the data analysis and personalized medicine space.
Guardant Health
GH
Mkt Cap11.85B
Guardant Health specializes in liquid biopsies and cancer diagnostics, competing with 10x Genomics in the genomic analysis market for oncology.
Twist Bioscience
TWST
Mkt Cap3.67B
Twist Bioscience operates in the synthetic biology space, producing synthetic DNA that is used in many of the same applications as 10x Genomics' products.

About

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
Show more...
CEO
Dr. Serge Saxonov Ph.D.
Employees
1178
Country
United States
ISIN
US88025U1097

Listings

0 Comments

Share your thoughts

FAQ

What is 10x Genomics stock price today?
The current price of 0A88.LSE is $21.2 USD — it has decreased by -2.36% in the past 24 hours. Watch 10x Genomics stock price performance more closely on the chart.
What is 10x Genomics stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange 10x Genomics stocks are traded under the ticker 0A88.LSE.
Is 10x Genomics stock price growing?
0A88.LSE stock has fallen by -18.52% compared to the previous week, the month change is a +6.96% rise, over the last year 10x Genomics has showed a +160.92% increase.
What is 10x Genomics market cap?
Today 10x Genomics has the market capitalization of 2.49B
When is the next 10x Genomics earnings date?
10x Genomics is going to release the next earnings report on May 07, 2026.
What were 10x Genomics earnings last quarter?
0A88.LSE earnings for the last quarter are -0.13 USD per share, whereas the estimation was -0.2 USD resulting in a +35.89% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is 10x Genomics revenue for the last year?
10x Genomics revenue for the last year amounts to 1.29B USD.
What is 10x Genomics net income for the last year?
0A88.LSE net income for the last year is -87.09M USD.
How many employees does 10x Genomics have?
As of April 24, 2026, the company has 1,178 employees.
In which sector is 10x Genomics located?
10x Genomics operates in the Other sector.
When did 10x Genomics complete a stock split?
10x Genomics has not had any recent stock splits.
Where is 10x Genomics headquartered?
10x Genomics is headquartered in Pleasanton, United States.